Media coverage about MISONIX (NASDAQ:MSON) has trended somewhat positive on Sunday, according to Accern Sentiment. Accern scores the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MISONIX earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.740175985476 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Shares of MISONIX (NASDAQ:MSON) traded up 1.89% during mid-day trading on Friday, hitting $8.45. 11,367 shares of the stock traded hands. The firm has a 50 day moving average of $8.63 and a 200 day moving average of $10.17. The company’s market cap is $76.24 million. MISONIX has a 12 month low of $4.85 and a 12 month high of $12.00.
MISONIX Company Profile
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for MISONIX Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MISONIX Inc. and related companies with MarketBeat.com's FREE daily email newsletter.